Considering that the biopsy site – the frontal cortex – is a region where tau pathology is typically observed in Braak stage V–VI,37, 38, 39 this finding supports the view that cortical biopsy can reliably reflect the staging of AD pathology. The gene discussed is MAPT; the disease is Alzheimer disease.